Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial.
Leuk Lymphoma. 2022 Aug;63(8):1871-1878. doi: 10.1080/10428194.2022.2095623. Epub 2022 Jul 18.
Leuk Lymphoma. 2022.
PMID: 35848865
Clinical Trial.
Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
Eichenauer DA, Bühnen I, Plütschow A, Kobe C, Dietlein M, Wendtner CM, Thorspecken S, Topp MS, Mauser M, von Tresckow B, Fuchs M, Borchmann P, Engert A.
Eichenauer DA, et al. Among authors: thorspecken s.
Hematol Oncol. 2022 Oct;40(4):801-804. doi: 10.1002/hon.2986. Epub 2022 Mar 24.
Hematol Oncol. 2022.
PMID: 35313381
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite